Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial
Titel:
Long-term outcomes after adjuvant treatment of sequential versus combination docetaxel with doxorubicin and cyclophosphamide in node-positive breast cancer: BCIRG-005 randomized trial
Auteur:
Mackey, J.R. Pieńkowski, T. Crown, J. Sadeghi, S. Martin, M. Chan, A. Saleh, M. Sehdev, S. Provencher, L. Semiglazov, V. Press, M.F. Sauter, G. Lindsay, M. Houé, V. Buyse, M. Drevot, P. Hitier, S. Bensfia, S. Eiermann, W.